Japan's Takeda nears Russia, Mideast asset sale to PE firms

Japan's Takeda nears Russia, Mideast asset sale to PE firms

Photo: Takeda Pharmaceutical website

Takeda Pharmaceutical Co. is nearing the sale of a portfolio of assets in the Middle East, Africa and Russia to separate buyout firms that could help the drugmaker raise about $1 billion to reduce debt, according to people familiar with the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter